Triple-negative breast cancer (TNBC) is the most aggressive and is characterized by the absence of three specific receptors: the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.